Generics 113

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cefaclor manufacturers

113 products found

Filters

Filters

Filters , active

Country of origin : Kazakshan

Clear all

113 products found

cefaclor

Oral powder 500 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17293
It was founded in the 1970s. It has developed rapidly since it introduced innovative promotional methods to the pharmaceutical market, and as a result, it established a prominent position in the field of Dermatology. its export activities are currently being developed in over 45 countries across five continents. The company has cooperated with the most reliable companies at a worldwide level, and by expanding its product portfolio, it now offers unique and effective solutions to several dermatological problems.

Manufacturer usually replies in 4 days

cefaclor

Syrup 125 mg , 250 mg , 500 mg - 50 ml , 75 ml , 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16182
It is a family-owned company based in Western Europe that specializes in the production of pediatric pharmaceuticals. All of the medicines give the added value that patients, physicians, and pharmacists have grown to expect from the company over the past 30 years as a top pediatric pharmaceutical company in the country. More than 130 products are available in the portfolio for a wide range of indications in dermatology, allergology, respiratory disorders, and ENT.

Manufacturer usually replies in 7 days

cefaclor

Tablets 250 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
Vietnam , United States
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

cefaclor

Granules for oral solution 500mg/5ml-60ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #12976
Established in the 1970s. They have a worldwide distribution network that provides customers with full sales and service support across 6 continents. They have over 4 decades of manufacturing experience. They are also a UK distributor for a high-speed DTG solution and specialize in folding and bagging systems.

Manufacturer usually replies in 6 days

cefaclor

Capsules 500mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #12976
Established in the 1970s. They have a worldwide distribution network that provides customers with full sales and service support across 6 continents. They have over 4 decades of manufacturing experience. They are also a UK distributor for a high-speed DTG solution and specialize in folding and bagging systems.

Manufacturer usually replies in 6 days

cefaclor

Capsules 250mg 500mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
United States , Vietnam
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

cefaclor

Tablets, modified release (MR) 375mg, 500mg, 750mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
United States , Vietnam
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

cefaclor

Oral suspension 125 mg/5 ml, 187 mg/5 ml, 250 mg/5 ml, 375 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
United States , Vietnam
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

cefaclor

Capsules 250mg, 500mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #16207

Manufacturer usually replies in 3 days

cefaclor

Oral drops 50 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29017

Manufacturer usually replies in nan days

cefaclor

Granules for oral suspension 375 mg ,125 mg/5 ml ,187.5 mg/5 ml , 375 mg/5 ml, 250 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29017

Manufacturer usually replies in nan days

cefaclor

Capsules, hard liquid 250 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29017

Manufacturer usually replies in nan days

cefaclor

Granules for oral suspension 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
EU GMP
Manufacturer #20853
The company’s mission is to invest in and operate businesses that restore health and enhances the lives of those they serve. Healthcare professionals use medicines and diagnostic devices to treat and manage infections, cardiovascular, metabolic, gastroenterological, rheumatic conditions, and more.

Manufacturer usually replies in 4 days

cefaclor

Oral suspension 125 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
EU GMP, PICS
Manufacturer #20652
It is a leading EU GMP-certified pharmaceutical company. It is focused on developing, manufacturing, and marketing branded off-patent pharmaceuticals, medical devices, and consumer healthcare products. The products are exported to countries in Asia Pacific, Africa, and the Middle East. Presence in over 22 countries. They have an experience of more than 50 years of in Southeast Asia.

Manufacturer usually replies in 5 days

cefaclor

Capsules, modified release (MR) 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #12677

Manufacturer usually replies in 4 days

cefaclor

Capsules 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #21646

Manufacturer usually replies in 1 days

cefaclor

Granules for oral suspension 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #21647

Manufacturer usually replies in 2 days

cefaclor

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

cefaclor

Oral suspension 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

Manufacturer usually replies in 12 days

cefaclor

Capsules 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

Want to view all 113 products? Create your free account today!

Cefaclor

Cefaclor is a second-generation cephalosporin antibiotic used to treat certain bacterial infections such as pneumonia and infections of the ear, throat, lung, skin, and urinary tract. Cefaclor is from a family of antibiotics called cephalosporins. They are broad-spectrum antibiotics used for the treatment of Septicaemia, meningitis, biliary tract infections pneumonia, peritonitis, and urinary tract infections. The makeup of the cephalosporins is similar to that of the Penicillins, excretion being principally renal. Cephalosporins’ ability to penetrate the cerebrospinal fluid is poor unless the meninges are already inflamed. Cefaclor is active against several bacteria, including both Gram-negative and Gram-positive organisms, in particular, targeted towards Haemophilus influenza, Staphylcoccus aureus, Streptococcus pyogenes. Cefaclor is marketed under the brand Ceclor among others. Eli Lily Italy is the main manufacturer & patent owner of Cefaclor. Cefaclor got patented in 1973 and approved for medical use in 1979.

Forms and Dosage

Cefaclor is sold as capsules and as extended-release tablets. In the treatment of Lower Respiratory Tract Infections, including pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus pyogenes, the standard prescribed dose in Capsules is 250-500 mg every 8 hours. In the treatment of Otitis Media, Capsules of 250-500 mg are prescribed to be administered every 8 hours. In the treatment of Uncomplicated Skin and Skin Structure Infections, the recommended dosage is 250-500 mg every 8 hours or an Extended-release tablet of 375 mg taken every 12 for 7-10 days. In the treatment of Urinary Tract Infections and Bronchitis the dosage of extended-release tablets of 250 mg every 8 hours and in the treatment of Pharyngitis and Tonsillitis, the patients are prescribed Capsules of 250-500 mg, to be taken every 8 hours or Extended-release tablets of 750 mg given every 12 hours for 10 days.

The cost of Cefaclor

In the USA, the consumers have to pay an average retail price of $115 usd for a supply of 30 capsules of 500 mg strength. In the United Kingdom, the same supply of 30 tables would cost 122 Euros.

How does it work?

Cefaclor actions exert bactericidal activity by interfering with bacterial cell wall synthesis and inhibiting the cross-linking of the peptidoglycan. The cephalosporins play a role in the activation of bacterial cell autolysins which may contribute to bacterial cell lysis. Cefaclor's actions work by stopping the growth of bacteria. Cefaclor is used in only the treatment of bacterial infections.

Finding Cefaclor Manufacturers and Cefaclor Suppliers

One of the fastest and easiest ways to find Cefaclor manufacturers and Cefaclor suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Usually, finding trusted manufacturers and supplies of specific drugs like Cefaclor can be a time- consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is make use of our integrated search engine and start looking for suppliers or manufacturers of Cefaclor to work with. You can fine-tune your search results using various filters too, letting you search for Cefaclor from specific countries, for example.